Vaxxas Home

Vaxxas Nanopatch™ Technology

Vaccine Application System
Nanopatch Microprojections
Pages > Investors > Investors

Vaxxas

Investors

Vaxxas Investors

OneVentures 
www.one-ventures.com.au

OneVentures is a venture capital firm that invests in emerging Australian technology companies with true breakout potential, differentiated technology and compelling business models in the clean technology, information technology and life sciences sectors.

OneVentures is managed by a team of partners with a skills set and track record ideally suited to collaboration with entrepreneurial management teams to foster growth and create value: a unique blend of highly successful entrepreneurs, technology business founders and corporate executives with a strong scientific pedigree, extensive off-shore experience and networks.  

The OneVentures Innovation Fund is a $40 million venture capital fund formed as an Early Stage Venture Capital Limited Partnership. The Commonwealth Government has committed $20 million from its IIF Program with this funding matched by high net worth Wholesale Investors.

 

Brandon Capital Partners 
www.brandoncapital.com.au

Brandon Capital Partners makes seed and venture capital investments to support the development and international growth of Australian life science companies. We work collaboratively with entrepreneurs to demonstrate the benefit of their technology, thereby creating value for them, their teams and our investors.

The $50 million Brandon Biosciences Fund 1 established in 2008. The investors include AustralianSuper and StatewideSuper, two of Australia's leading industry super funds as well as the Australian Government under its IIF program.

 

The Medical Research Commercialisation Fund (MRCF) 
www.mrcf.com.au

The $51 million Medical Research Commercialisation Fund (MRCF) Collaboration is an innovative investment collaboration established in 2007 and is managed by Brandon Capital Partners. The MRCF invests in early stage development and commercialisation opportunities emanating from its membership of 32 Australian medical research institutes and their allied research hospitals, which includes the Australian Institute for Bioengineering and Nantechnology (AIBN). The MRCF IIF, LP fund is supported by AustralianSuper, StatewideSuper and the Australian Government under its IIF program. The MRCF also acknowledges the support of the State Governments of Victoria, New South Wales, Western Australia and Queensland.

 

HealthCare Ventures LLC 
www.hcven.com

HealthCare Ventures is a leading life science venture capital firm investing in preclinical and early clinical stage "Focused Companies" with the potential to transform patient care. Since its founding in 1985, HealthCare Ventures has raised $1.6 billion across nine funds and has invested in 106 companies, 68 as start-up ventures.